A 2021 New England Journal of Medicine study published August 5, 2021, in volume 385, issue 6, pages 516–525, compared milrinone with dobutamine for treating cardiogenic shock.
Notes on verification
Citation details (volume, issue, pages, date) and study content confirmed by NEJM, PubMed, and independent cardiology news source TCTMD. [tier=gold indep_score=0.983 clusters=3 claim_tier=everyday]
Sources
- Publications - Pietro Di Santo, M.D., Ph.D. - Mayo Clinic (seed:health_and_medicine)
- https://www.nejm.org/doi/full/10.1056/NEJMoa2026845 (corroboration)
- https://pubmed.ncbi.nlm.nih.gov/34347952/ (corroboration)
- https://www.tctmd.com/news/milrinone-dobutamine-comparable-cardiogenic-shock-doremi (corroboration)